KR
Kalpana Ravanaboina
About Kalpana Ravanaboina
Data last updated:
Kalpana Ravanaboina is a Director at Cronies Pharma & Bio-Sciences Private Limited (since 2016), Director at Velzen Pharma Private Limited (since 2023) and Director at Vnh Pharmaceuticals Private Limited (since 2017), and holds 1 more current directorship. The companies operate in Pharma and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹4.86 Cr; the largest is Cronies Pharma & Bio-Sciences Private Limited at ₹2.19 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cronies Pharma & Bio-Sciences Private Limited U74999TG2016PTC109657 | Director | 14 May 2016 | 2016 | ₹2.19 Cr (FY 2025) | Active |
 Velzen Pharma Private Limited U24239TG2022PTC161052 | Director | 20 Sep 2023 | 2022 | ₹2.07 Cr (FY 2025) | Active |
| Vnh Pharmaceuticals Private Limited U24290TG2017PTC117352 | Director | 25 May 2017 | 2017 | ₹60.6 Lakh (FY 2021) | Active |
| Vnh Life Sciences Private Limited U46497TS2025PTC193548 | Non- Individual Subscriber | 30 Jan 2025 | 2025 | Active |
Board colleagues of Kalpana Ravanaboina
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kirankumar Velaveni | 06992040 | Cronies Pharma & Bio-Sciences Private Limited , Velzen Pharma Private Limited | Director |
| Anasuya Panyala | 09553515 | Velzen Pharma Private Limited | Director |
| Sanjay Verma | 09553514 | Velzen Pharma Private Limited | Director |
| Mateti Srinivas | 07774510 | Vnh Pharmaceuticals Private Limited , Vnh Life Sciences Private Limited | Director |
| Mora Suman Kumar | 07822771 | Vnh Pharmaceuticals Private Limited | Director |
| Santosh Kumar Boddu | 07774552 | Vnh Pharmaceuticals Private Limited | Director |
| Suresh Kumar Thatipamula | 09833005 | Vnh Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kalpana Ravanaboina
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kalpana Ravanaboina
Kalpana Ravanaboina currently holds 4 directorships: Cronies Pharma & Bio-Sciences Private Limited (Director, since 14 May 2016, revenue ₹2.19 Cr (FY 2025)); Velzen Pharma Private Limited (Director, since 20 Sep 2023, revenue ₹2.07 Cr (FY 2025)); Vnh Pharmaceuticals Private Limited (Director, since 25 May 2017, revenue ₹60.6 Lakh (FY 2021)); Vnh Life Sciences Private Limited (Non- Individual Subscriber, since 30 Jan 2025).
Kalpana Ravanaboina was first appointed on 14 May 2016 as Director at Cronies Pharma & Bio-Sciences Private Limited. The most recent appointment on record is 30 Jan 2025 at Vnh Life Sciences Private Limited.
The 3 current companies of Kalpana Ravanaboina that report revenue have a combined latest revenue of ₹4.86 Cr: Cronies Pharma & Bio-Sciences Private Limited ₹2.19 Cr (FY 2025); Velzen Pharma Private Limited ₹2.07 Cr (FY 2025); Vnh Pharmaceuticals Private Limited ₹60.6 Lakh (FY 2021).
The current boards of Kalpana Ravanaboina's companies include Kirankumar Velaveni (Cronies Pharma & Bio-Sciences Private Limited), Anasuya Panyala (Velzen Pharma Private Limited), Sanjay Verma (Velzen Pharma Private Limited), Mateti Srinivas (Vnh Pharmaceuticals Private Limited), Mora Suman Kumar (Vnh Pharmaceuticals Private Limited), Santosh Kumar Boddu (Vnh Pharmaceuticals Private Limited), among others.